Loading clinical trials...
Loading clinical trials...
Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies
Conditions
Interventions
Eptinezumab
Locations
28
United States
Neuropain Medical Center
Fresno, California, United States
Sunwise Clinical Research, LLC.
Oakland, California, United States
The Neuron Clinic
San Marcos, California, United States
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute
Aurora, Colorado, United States
Advanced Neurology of Colorado, LLC
Longmont, Colorado, United States
Research of the Rockies
Parker, Colorado, United States
Start Date
December 18, 2024
Primary Completion Date
June 5, 2026
Completion Date
June 5, 2026
Last Updated
March 9, 2026
NCT06735833
NCT06241313
NCT06641466
NCT07018713
NCT04715685
NCT07476053
Lead Sponsor
H. Lundbeck A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions